The anti-CD74 humanized monoclonal antibody, milatuzumab, which targets the invariant chain of MHC II complexes, alters B-cell proliferation, migration, and adhesion molecule expression

INTRODUCTION: Targeting CD74 as the invariant chain of major histocompatibility complexes (MHC) became possible by the availability of a specific humanized monoclonal antibody, milatuzumab, which is under investigation in patients with hematological neoplasms. CD74 has been reported to regulate chem...

詳細記述

保存先:
書誌詳細
主要な著者: Frölich, Daniela, Blaβfeld, Daniela, Reiter, Karin, Giesecke, Claudia, Daridon, Capucine, Mei, Henrik E, Burmester, Gerd R, Goldenberg, David M, Salama, Abdulagabar, Dörner, Thomas
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2012
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3446420/
https://ncbi.nlm.nih.gov/pubmed/22404985
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar3767
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料